Literature DB >> 27169519

Reduction in central venous pressure enhances erythropoietin synthesis: role of volume-regulating hormones.

D Montero1, S Rauber1, J P Goetze2, C Lundby3,4.   

Abstract

AIMS: Erythropoiesis is a tightly controlled biological event, but its regulation under non-hypoxic conditions, however, remains unresolved. We examined whether acute changes in central venous blood pressure (CVP) elicited by whole-body tilting affect erythropoietin (EPO) concentration according to volume-regulating hormones.
METHODS: Plasma EPO, angiotensin II (ANGII), aldosterone, pro-atrial natriuretic peptide (proANP) and copeptin concentrations were measured at supine rest and up to 3 h during 30° head-up (HUT) and head-down tilt (HDT) in ten healthy male volunteers. Plasma albumin concentration was used to correct for changes in plasma volume and CVP was estimated through the internal jugular vein (IJV) aspect ratio with ultrasonography.
RESULTS: From supine rest, the IJV aspect ratio was decreased and increased throughout HUT and HDT respectively. Plasma EPO concentration increased during HUT (13%; P = 0.001, P for linear component = 0.017), independent of changes in albumin concentration. Moreover, ANGII and copeptin concentrations increased during HUT, while proANP decreased. The increase in EPO concentration during HUT disappeared when adjusted for changes in copeptin. During HDT, EPO, ANGII and copeptin concentrations remained unaffected while proANP increased. In regression analyses, EPO was positively associated with copeptin (β = 0.55; 95% CI = 0.18, 0.93; P = 0.004) irrespective of changes in other hormones and albumin concentration.
CONCLUSION: Reduction in CVP prompts an increase in plasma EPO concentration independent of hemoconcentration and hence suggests CVP per se as an acute regulator of EPO synthesis. This effect may be explained by changes in volume-regulating hormones.
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  angiotensin II; central venous pressure; erythropoiesis; vasopressin

Mesh:

Substances:

Year:  2016        PMID: 27169519     DOI: 10.1111/apha.12708

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  6 in total

1.  Age-dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients.

Authors:  David Montero; Thomas Haider; Jens Barthelmes; Jens P Goetze; Silviya Cantatore; Carsten Lundby; Isabella Sudano; Frank Ruschitzka; Andreas J Flammer
Journal:  Physiol Rep       Date:  2019-03

2.  Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction.

Authors:  David Montero; Thomas Haider; Jens Barthelmes; Jens P Goetze; Silviya Cantatore; Isabella Sudano; Frank Ruschitzka; Andreas J Flammer
Journal:  Physiol Rep       Date:  2019-11

3.  Sex Differences in Orthostatic Tolerance Are Mainly Explained by Blood Volume and Oxygen Carrying Capacity.

Authors:  Candela Diaz-Canestro; Brandon Pentz; Arshia Sehgal; David Montero
Journal:  Crit Care Explor       Date:  2022-01-05

4.  Differences in Cardiac Output and Aerobic Capacity Between Sexes Are Explained by Blood Volume and Oxygen Carrying Capacity.

Authors:  Candela Diaz-Canestro; Brandon Pentz; Arshia Sehgal; David Montero
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

5.  Unexplained Anemia in the Elderly: Potential Role of Arterial Stiffness.

Authors:  David Montero; Candela Diaz-Cañestro; Andreas Flammer; Carsten Lundby
Journal:  Front Physiol       Date:  2016-10-25       Impact factor: 4.566

6.  Effect of variability of central venous pressure values to prevent atrial fibrillation after coronary bypass grafting.

Authors:  Seyed Hossein Hamidi; Ghasem Faghanzadeh-Ganji; Ali Baghaeian; Ali Bijani; Roghaieh Pourkia
Journal:  Caspian J Intern Med       Date:  2021-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.